What Evonik Industries does

Evonik Industries AG is a German specialty chemicals company headquartered in Essen, Germany, with approximately 31,000 employees globally and operations across Europe, North America, Latin America, Asia Pacific, and the Middle East/Africa. Founded in 2007 and listed on the Frankfurt Stock Exchange (MDAX) since April 2013, Evonik operates through three primary reporting segments — Specialty Additives, Nutrition & Care, and Smart Materials — selling specialty chemicals, high-performance polymers, membranes, pharmaceutical excipients, biosurfactants, and active oxygen compounds to industrial customers in automotive, aerospace, pharmaceutical, personal care, construction, energy, and agriculture markets.

The company's core technology portfolio is built around proprietary branded platforms including EUDRAGIT functional film coating polymers and EUDRACAP colon-targeting capsules for oral drug delivery; SEPURAN Green and DURAION anion exchange membranes for biogas upgrading and green hydrogen electrolysis; AEROXIDE specialty oxides for lithium-ion battery applications; TEGO coating additives and defoamers; VESTAMID high-performance polyamides; SIPERNAT and ULTRASIL precipitated silicas (including ISCC Plus-certified ULTRASIL eCO); VISIOMER specialty methacrylates; and an industrial-scale rhamnolipid biosurfactants platform. Evonik also operates an Advanced Technologies CDMO business producing spider-silk proteins and pharmaceutical lipids for mRNA and gene delivery applications, with an €80 million downstream fermentation expansion underway at its Slovenská Ľupča, Slovakia biotechnology hub.

Evonik generates revenue primarily through B2B direct enterprise sales under quote-based pricing, supplemented by regional channel distributors for specific product lines (e.g., First Quality Chemicals in Mexico for Care Solutions and Active Oxygens). The company's revenue model spans one-time sales of specialty chemicals across segments plus professional services revenue from CDMO contracts. In 2025, sales totaled €14.1 billion (down 7% year-over-year), but Q2 2026 adjusted EBITDA of €600–650 million exceeded consensus of €567 million by more than 5%, prompting management to raise full-year 2026 adjusted EBITDA guidance to €2.0–2.2 billion from a prior €1.7–2.0 billion range. The company is undergoing a multi-year restructuring (the "Tailor Made" program) targeting €400 million in annual savings, with a planned exit of the unprofitable polyester business in 2027. RAG-Stiftung holds approximately 44% of the 466 million outstanding shares.

Name

Evonik Industries

Legal name

Evonik Industries AG

Website

https://corporate.evonik.com

Company type

Public

Founded year

2007

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Evonik Industries AG is a German specialty chemicals company that produces specialty additives, high-performance polymers, membranes, pharmaceutical excipients, biosurfactants, and active oxygen compounds for industrial customers across automotive, aerospace, pharmaceutical, personal care, construction, and energy end markets globally.

Ownership category

akta.pro rank

Product category

Specialty Chemicals

NAICS

Paint, Coating, and Adhesive Manufacturing (3255), Adhesive Manufacturing (325520), Resin and Synthetic Rubber Manufacturing (32521), Custom Compounding of Purchased Resins (325991), Petrochemical Manufacturing (325110)

SIC

Industrial Organic Chemicals (2860), Chemicals & Allied Products (2800), Miscellaneous Chemical Products (2890), Plastic Materials, Synth Resins & Nonvulcan Elastomers (2821), Paints, Varnishes, Lacquers, Enamels & Allied Prods (2851), Adhesives & Sealants (2891)

akta.pro primary industry

Personal Care & Cosmetic Ingredients (IMAEABAJ)

akta.pro secondary industries

Synthetic Rubber & Elastomer Feedstocks (SBR, BR, NBR, EPDM) (IMAEADAJ), Bio-based Adhesives, Coatings & Sealants (lignin/tannin/soy-based) (IMAMALAG), Bio-based Resins, Adhesives, Coatings & Sealants (EUAAAIAG)

Keywords

• Specialty chemicals
• Pharmaceutical excipients
• Coating additives
• Animal nutrition
• High-performance polymers

Headquarters

HQ city

Essen

HQ country

Germany

HQ region

Europe

Offices12 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

1. Specialty Additives: Sale of specialty chemical additives for coatings, adhesives, construction, and industrial applications. Core business segment generating significant portion of group revenue.
2. Nutrition & Care: Sale of products for animal nutrition (methionine), personal care ingredients, and health care solutions including pharmaceutical excipients and drug delivery systems.
3. Smart Materials: Sale of high-performance polymers, membranes, and specialty chemicals for automotive, aerospace, electronics, and energy applications.
4. Advanced Technologies: Contract development and manufacturing (CDMO) services for pharmaceutical industry, including biopharmaceutical production and drug delivery solutions.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Evonik Industries AG manufactures and sells specialty chemicals across three reporting segments: Specialty Additives, Nutrition & Care, and Smart Materials. Its portfolio includes active oxygens (hydrogen peroxide, peracetic acid, persulfates), pharmaceutical excipients and drug delivery systems (EUDRAGIT, EUDRACAP, PhytoChol), high-performance polymers and membranes (VESTAMID polyamides, SEPURAN, DURAION), coating additives (TEGO defoamers), animal nutrition products (methionine), care solutions (rhamnolipid biosurfactants), catalysts, silica, and methacrylates. The company also offers contract development and manufacturing (CDMO) services for biopharmaceutical customers.

Product overview

Evonik Industries is a German specialty chemicals company organized around multiple business lines covering distinct product categories. The core product portfolio includes Active Oxygens (hydrogen peroxide, peracetic acid, persulfates), Health Care (EUDRAGIT film coatings, EUDRACAP capsules, pharmaceutical lipids for mRNA delivery), High Performance Polymers (VESTAMID polyamides, DURAION anion exchange membranes), Coating Additives (TEGO defoamers, rheology modifiers), Care Solutions (personal care ingredients), Animal Nutrition (methionine products), Catalysts, Smart Effects (specialty silica including SIPERNAT, ULTRASIL), Oil Additives (lubricant additives, methacrylates, immersion cooling), and crosslinking agents. Key technology platforms include SEPURAN Green membranes for biogas and hydrogen, Rhamnolipids biosurfactants, AEROXIDE specialty oxides for batteries, and the Innovation Factory initiative including DURAION and Rheticus projects. The company serves diverse end markets including automotive, aerospace, healthcare, personal care, coatings, construction, energy, and agriculture through its three reporting segments: Specialty Additives, Nutrition & Care, and Smart Materials.

Differentiator

Problem solved

Functional benefit

Brands

• TEGO: Brand for coating additives and antifoam products including TEGO Foamex 8051
• EUDRAGIT
• SIPERNAT
• VISIOMER
• SEPURAN
• AEROXIDE
• VESTAMID
• PhytoChol
• X50 CellEssence
• DURAION
• ECOBIOL

Products and services

• Active Oxygens Produces and supplies hydrogen peroxide, peracetic acid, persulfates, and calcium peroxide for aerospace, agriculture, cleaning, cosmetics, electronics, energy, mining, environment, food & beverage, pharma, and pulp applications.
• EUDRAGIT

Quantifiable outcome

• Q2 2026 adjusted EBITDA of €600-650 million exceeded consensus of €567 million by more than 5%
• +3 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Seven partnerships are on record, tiered minor, core and flagship.

• ProChem GroupminorImplementation/ SI/ Consulting Partner · 19 June 2026Evonik sold selected pharmaceutical ingredient manufacturing assets at its Hanau facility in Germany to contract manufacturing specialist ProChem Group. Transaction expected to close June 19, 2026, as part of Evonik's strategy to sharpen Health Care business focus on advanced drug delivery systems.
• University of Guanajuato (School of Mining)coreStrategic or Co-development Partner · 1 June 2026Evonik entered a strategic partnership with the School of Mining at the University of Guanajuato in Mexico to develop next-generation sustainable and lower-toxicity chemical solutions for mining applications using Evonik's rhamnolipid biosurfactants platform.
• Vary TechflagshipStrategic or Co-development Partner · 11 May 2026Vary Tech and Evonik partnered to launch a full-industry chain process package for chemically recycling mixed waste plastics into high-quality Plastic Pyrolysis Oil (PPO) and circular naphtha. The partnership established CARBON LOOP SYSTEMS PTE. LTD. in Singapore and signed MOU with JE Synergy for Asia's first closed-loop chemical recycling demonstration project.
• SupeZETflagshipStrategic or Co-development Partner · 11 May 2026SupeZET partnered with Evonik and Vary Tech to provide hydrogenation and fractionation technology for chemical recycling of plastic waste into circular naphtha. Combined with Evonik's Rocket purification module and Vary Tech's pyrolysis technology.
• JE SynergyflagshipStrategic or Co-development Partner · 11 May 2026Partnership with JE Synergy signed to build Asia's first closed-loop chemical recycling demonstration project for post-consumer municipal plastics, supporting Singapore's Zero Waste Masterplan.
• AmsilkcoreTechnology or Integration · 27 April 2026Evonik's Slovenská Ľupča site produces spider-silk protein for Munich-based Amsilk, representing a key biotechnology partnership in the CDMO services business.
• First Quality ChemicalscoreChannel Partner/ Reseller/ Distributor · 1 April 2026First Quality Chemicals appointed as authorized distributor in Mexico for Evonik's Care Solutions and Active Oxygens product lines, effective April 1, 2026, replacing a previous multinational distributor based on commercial capabilities.

Scale indicators11 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• BASF: Largest German chemical company and Evonik's most direct competitor across specialty additives, coatings, and performance materials. Both serve automotive, construction, and agricultural end markets with overlapping portfolios.
• Covestro: German specialty materials producer with strong overlap in high-performance polymers, coatings raw materials, and adhesives. Comparable business mix and European industrial customer base.
• Lanxess: Cologne-based specialty chemicals company serving automotive, construction, and industrial markets. Direct overlap with Evonik in additives, rubber chemicals, and performance intermediates.
• Wacker Chemie: Munich-based specialty chemicals company with comparable exposure to silicones, polymers, and biotech. Overlaps with Evonik in silica, polysiloxanes, and biopharmaceutical contract manufacturing.
• Arkema: French specialty chemicals company with comparable presence in adhesives, coating solutions, and advanced materials. Direct competitor in several of Evonik's high-performance polymer and additive segments.
• DSM-Firmenich: Dutch specialty ingredients company with strong overlap in nutrition, personal care, and health. Comparable to Evonik's Nutrition & Care segment, including methionine-adjacent animal nutrition exposure.
• Croda International: UK-listed specialty ingredients company focused on personal care, life sciences, and performance technologies. Comparable to Evonik's Care Solutions and biosurfactant initiatives.

Broad incumbents

• Solvay: Belgian specialty chemicals leader with broad portfolio including specialty polymers, composites, and soda ash. Overlaps Evonik in advanced materials and additives for industrial customers.
• DuPont: US-based specialty chemicals incumbent with broad portfolio spanning electronics, healthcare, and industrial markets. Overlaps Evonik in high-performance polymers, pharma excipients, and specialty additives.
• AkzoNobel: Global paints and coatings major with significant overlap with Evonik's Coating Additives business (TEGO, defoamers, rheology modifiers). Major customer for Evonik's coating chemistry inputs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/user/EvonikIndustries
• Facebookfacebook.com/EvonikHP
• LinkedInlinkedin.com/company/evonik
• Instagraminstagram.com/evonikofficial
• TikToktiktok.com/@evonikofficial
• Xx.com/Evonik

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Subsidiaries4 records

Funding overview

Funding rounds5 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A17 records

Investments6 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Evonik Industries